These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1846552

  • 21. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S, Benchokroun Y, Larsen AK.
    Mol Pharmacol; 1995 May; 47(5):898-906. PubMed ID: 7746278
    [Abstract] [Full Text] [Related]

  • 22. The function of DNA topoisomerases in UV-induced DNA excision repair: studies with specific inhibitors in permeabilized human fibroblasts.
    Popanda O, Thielmann HW.
    Carcinogenesis; 1992 Dec; 13(12):2321-8. PubMed ID: 1335377
    [Abstract] [Full Text] [Related]

  • 23. DNA supercoiling changes and nuclear matrix-associated proteins: possible role in oncogene-mediated radioresistance.
    Malyapa RS, Wright WD, Taylor YC, Roti Roti JL.
    Int J Radiat Oncol Biol Phys; 1996 Jul 15; 35(5):963-73. PubMed ID: 8751405
    [Abstract] [Full Text] [Related]

  • 24. HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
    Zwelling LA, Slovak ML, Doroshow JH, Hinds M, Chan D, Parker E, Mayes J, Sie KL, Meltzer PS, Trent JM.
    J Natl Cancer Inst; 1990 Oct 03; 82(19):1553-61. PubMed ID: 1976136
    [Abstract] [Full Text] [Related]

  • 25. Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family.
    Chang EH, Pirollo KF, Zou ZQ, Cheung HY, Lawler EL, Garner R, White E, Bernstein WB, Fraumeni JW, Blattner WA.
    Science; 1987 Aug 28; 237(4818):1036-9. PubMed ID: 3616624
    [Abstract] [Full Text] [Related]

  • 26. Cellular and chromosomal hypersensitivity to DNA crosslinking agents and topoisomerase inhibitors in the radiosensitive Chinese hamster irs mutants: phenotypic similarities to ataxia telangiectasia and Fanconi's anaemia cells.
    Jones NJ, Ellard S, Waters R, Parry EM.
    Carcinogenesis; 1993 Dec 28; 14(12):2487-94. PubMed ID: 8269616
    [Abstract] [Full Text] [Related]

  • 27. Regenerating rat liver topoisomerase II: purification of the enzyme and catenation of DNA rings.
    Mirambeau G, Lavenot C, Duguet M.
    Adv Exp Med Biol; 1984 Dec 28; 179():423-33. PubMed ID: 6098161
    [No Abstract] [Full Text] [Related]

  • 28. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P, Nagaraja V.
    Mol Microbiol; 2005 Dec 28; 58(5):1392-405. PubMed ID: 16313624
    [Abstract] [Full Text] [Related]

  • 29. Positive supercoiling catalysed in vitro by ATP-dependent topoisomerase from Desulfurococcus amylolyticus.
    Slesarev AI.
    Eur J Biochem; 1988 Apr 15; 173(2):395-9. PubMed ID: 2834207
    [Abstract] [Full Text] [Related]

  • 30. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
    Giaccone G, Gazdar AF, Beck H, Zunino F, Capranico G.
    Cancer Res; 1992 Apr 01; 52(7):1666-74. PubMed ID: 1312895
    [Abstract] [Full Text] [Related]

  • 31. Cellular consequences of overproduction of DNA topoisomerase II in an ataxia-telangiectasia cell line.
    Smith PJ, Makinson TA.
    Cancer Res; 1989 Mar 01; 49(5):1118-24. PubMed ID: 2537142
    [Abstract] [Full Text] [Related]

  • 32. Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.
    Salceda J, Fernández X, Roca J.
    EMBO J; 2006 Jun 07; 25(11):2575-83. PubMed ID: 16710299
    [Abstract] [Full Text] [Related]

  • 33. Functional expression of human topoisomerase II alpha in yeast: mutations at amino acids 450 or 803 of topoisomerase II alpha result in enzymes that can confer resistance to anti-topoisomerase II agents.
    Hsiung Y, Jannatipour M, Rose A, McMahon J, Duncan D, Nitiss JL.
    Cancer Res; 1996 Jan 01; 56(1):91-9. PubMed ID: 8548781
    [Abstract] [Full Text] [Related]

  • 34. Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.
    Zwelling LA, Mitchell MJ, Satitpunwaycha P, Mayes J, Altschuler E, Hinds M, Baguley BC.
    Cancer Res; 1992 Jan 01; 52(1):209-17. PubMed ID: 1309224
    [Abstract] [Full Text] [Related]

  • 35. Cell cycle effects of the DNA topoisomerase inhibitors camptothecin and m-AMSA in lymphoblastoid cell lines from patients with Fanconi anemia.
    Poot M, Epe B, Hoehn H.
    Mutat Res; 1992 Nov 16; 270(2):185-9. PubMed ID: 1383735
    [Abstract] [Full Text] [Related]

  • 36. Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line.
    Webb CD, Latham MD, Lock RB, Sullivan DM.
    Cancer Res; 1991 Dec 15; 51(24):6543-9. PubMed ID: 1660341
    [Abstract] [Full Text] [Related]

  • 37. Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II.
    Hofmann GA, Mirabelli CK, Drake FH.
    Anticancer Drug Des; 1990 Aug 15; 5(3):273-82. PubMed ID: 2169250
    [Abstract] [Full Text] [Related]

  • 38. Identification of DNA topoisomerase-II activity in terminally differentiated mammalian organs and in non-growing cultured cells.
    Holden JA, Dresler SL, Low RL.
    Enzyme; 1990 Aug 15; 43(4):197-206. PubMed ID: 1966287
    [Abstract] [Full Text] [Related]

  • 39. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
    Mo YY, Beck WT.
    Oncol Res; 1997 Aug 15; 9(4):193-204. PubMed ID: 9268990
    [Abstract] [Full Text] [Related]

  • 40. Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
    Bugg BY, Danks MK, Beck WT, Suttle DP.
    Proc Natl Acad Sci U S A; 1991 Sep 01; 88(17):7654-8. PubMed ID: 1652758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.